Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1989-08-22
1993-04-13
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Lymphokine
514 2, 514 12, 514 8, 514 21, A61K 3702
Patent
active
052021173
ABSTRACT:
A thrombus control agent comprising a human granulocyte colony stimulating factor (human G-CSF) as an active ingredient and a pharmaceutically acceptable carrier, a method of treating thrombi by administering the thrombus control agent to a patient bearing thrombi formed in the arterial and venous vessels, and use of human G-CSF for preparing the thrombus control agent are disclosed.
The inventors found that human G-CSF is useful for treating thrombi and developed the use of human G-CSF for this purpose although nobody has clearly reported this type of pharmacological activity of human G-CSF.
REFERENCES:
patent: 4766075 (1988-08-01), Goeddel et al.
patent: 5120534 (1992-06-01), Hirai et al.
patent: 5126325 (1992-06-01), Kishimoto
Morsteyn et al., J. Clin. Cencalopy 1989, vol. 7(10), pp. 1554-62.
Tanikawa et al., Exp. Hematol. 17 1989, pp. 883-88.
Kojima et al., J. Cell Physiol. 138(1) 1989, pp. 192-96 (abst. only).
Verstraete et al., Blood 67(6) 1986, pp. 1529-41.
Cohen et al., PNAS 84, 1987 pp. 2484-28.
H. Hagiwara et al., (1984) Thrombosis Res. 33: 363-370.
M. Shimonaka et al., (1984) Thrombosis Res. 36: 217-222.
Y. Inada et al., (1985) Biochem. Biophys. Res. Commun. 130: 182-187.
S. Kojima et al. (1986) Biomedical Res. 7:155-159.
Ono Masayoshi
Tsuji Koichiro
LandOfFree
Method of treating thrombi with G-CSF does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating thrombi with G-CSF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating thrombi with G-CSF will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1153876